Systemic sclerosis medications and risk of scleroderma renal crisis

Overview of attention for article published in BMC Nephrology, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 36,871 followers.

全身性硬化症の患者さんにはACE阻害薬は控えた方がいい？（少なくとも増量しない）

【後ろ向きコホート研究】全身性硬化症診断時のACE阻害薬の使用は強皮症腎クリーゼのリスク増加と関連した。全身性硬化症診断後の、ACE阻害薬の投与量の倍増および最大用量の達成はその後の強皮症腎クリーゼと関連した。 https://t.co/v3zcLnJj39

RT @RheumNow: Cohort study shows ACE inhib. in Systemic Sclerosis at Dx was assoc w/ increased risk for Scleroderma Renal Crisis (SRC). Mi…

RT @RheumNow: Cohort study shows ACE inhib. in Systemic Sclerosis at Dx was assoc w/ increased risk for Scleroderma Renal Crisis (SRC). Mi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.